Frazier Life Sciences Management’s Savara SVRA Stock Holding History

Frazier Life Sciences Management’s Portfolio SVRA Stock Details SVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$53.1M	Sell	9,720,852 -141,449	-1%	-$787K	1.37%	17
2025 Q4	$59.5M	Sell	9,862,301 -1,600,000	-14%	-$7.84M	1.6%	18
2025 Q3	$40.9M	Hold	11,462,301	–	–	1.23%	20
2025 Q2	$26.1M	Hold	11,462,301	–	–	1.05%	21
2025 Q1	$31.8M	Buy	11,462,301 +2,801,922	+32%	+$7.74M	1.45%	17
2024 Q4	$26.6M	Buy	8,660,379 +502,994	+6%	+$1.75M	1.1%	22
2024 Q3	$34.6M	Hold	8,157,385	–	–	1.39%	22
2024 Q2	$32.9M	Buy	8,157,385 +4,157,385	+104%	+$18.5M	1.54%	21
2024 Q1	$19.9M	Hold	4,000,000	–	–	0.84%	32
2023 Q4	$18.8M	Hold	4,000,000	–	–	1.01%	28
2023 Q3	$15.1M	Buy	+4,000,000	New	+$14.3M	1.01%	23

Other funds holding SVRA

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return